Sodium oxybate in treatment-resistant rapid-eye-movement sleep behavior disorder

STUDY OBJECTIVES: Symptomatic therapies for rapid-eye-movement (REM) sleep behavior disorder (RBD) are limited. Sodium oxybate (SXB), a gamma-aminobutyric acid (GABA)-B agonist, could be effective but has not been evaluated against placebo. METHODS: This double-blind, parallel-group, randomized, pla...

Descripción completa

Detalles Bibliográficos
Autores principales: During, Emmanuel H, Hernandez, Beatriz, Miglis, Mitchell G, Sum-Ping, Oliver, Hekmat, Anahid, Cahuas, Ana, Ekelmans, Adrian, Yoshino, Fuyumi, Mignot, Emmanuel, Kushida, Clete A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Neurological Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424170/
https://www.ncbi.nlm.nih.gov/pubmed/37052688
http://dx.doi.org/10.1093/sleep/zsad103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424170/
https://www.ncbi.nlm.nih.gov/pubmed/37052688
http://dx.doi.org/10.1093/sleep/zsad103

Ejemplares similares